This week, the CDC launched a suite of new opioid prescribing guideline resources for providers, including a mobile app and video series. This is a follow-up to their CDC Guideline for Prescribing Opioids for Chronic Pain, launched last spring, to encourage safer and more effective pain management. 

According to the CDC, “The new Opioid Guide App makes it easier to apply the recommendations in the CDC Guideline for Prescribing Opioids for Chronic Pain into clinical practice by putting the entire guideline, tools and resources in the palm of your hand.” 

The free mobile app, available for Apple and Android devices, features:

  • A Morphine Milligram Equivalent (MME) Calculator
  • Prescribing Guidance
  • Motivational Interviewing (MI) feature to practice effective communication skills

In addition to the app, CDC has developed a video series to help improve understanding about prescription opioids to encourage communication between clinicians and patients. An example of the videos, Even When Prescribed by a Doctor, raises general awareness about opioids and can be shared on social media or used in training sessions or presentations. 

The data suggests there is more work to do, and we stand with our partners and stakeholders to deliver impact. For more information on how the AHA is addressing the opioid abuse crisis, visit: aha.org/behavioralhealth/opioids. To access CDC’s tools and resources, visit: cdc.gov/drugoverdose/prescribing/resources.html.  

Related News Articles

Headline
The Centers for Medicare & Medicaid Services today released an updated tool for viewing and comparing opioid prescribing rates over time and across regions.
Headline
The Department of Health and Human Services has updated its guidance to help communities prepare for and respond to chemical incidents requiring mass…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic last week held a webinar on the work it will undertake over the…
Headline
The Centers for Medicare & Medicaid Services has extended the deadline for submitting third-quarter data to the Post-Acute Care Quality Reporting Program.
Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
Hospitals and clinicians are seeing fewer flu patients this season than in other recent years, the Centers for Disease Control and Prevention reports.